MedTrace Logo

Effect Of Breather On Pulmonary And Physical Function In Post Stroke Survivors

NCT05678816 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-01-10

No results posted yet for this study

Summary

Stroke is the second major cause of death and disability worldwide with over 13 million new cases annually.

Egypt, a low-middle-income country, is the most populated nation in the Middle East with a high overall crude prevalence rate of stroke (963/100,000 inhabitants), accounting for 6.4% of all deaths and the incidence of stroke annually is approximately 150,000-210,000.

Stroke has a direct impact on health systems, resulting in high costs, and is also considered a global public health problem due to serious disabilities, functional limitations and compromised quality of life (QoL).

The Breather a drug-free, evidence-based inspiratory/expiratory respiratory muscle training (RMT) device used by Dysphagia, COPD, CHF, Parkinson's, and neuromuscular disease patients, as well as children 4+ and adults interested in healthy aging.

Conditions

Interventions

DEVICE

BREATHER

respiratory muscle trainer used to strength inspiratory an expiratory muscles through breathing in and out against aresistence which is determined individually according to each patient.

OTHER

physiotherapy prgramme for rehabilitation of stroke patients

physiotherapy prgramme for rehabilitation of stroke patients which include: * Passive stretching exercise, strengthening exercise. * Postural control and balance exercise from different positions as quadruped, kneeling, sitting and standing. * Gait training.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • NESREEN AL NAHAS, PROFESSOR · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-15
Primary Completion
2022-12-15
Completion
2022-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05678816 on ClinicalTrials.gov